Atractylis aristata

Atractylis aristata · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Atractylis aristata is a botanical species recognized for its significant presence of bioactive flavonoids. Scientific investigations into its aqueous and n-butanol extracts have revealed a diverse range of therapeutic potentials. The plant has demonstrated promising effects when utilized as antidiabetic agents and in the management of anxiety. Furthermore, it plays a crucial role in addressing biological challenges such as inflammation and oxidative stress. These medicinal properties highlight the plant's importance in pharmacological research and natural product development.

Quick facts
Synonyms
Not available
Common names
Not available
Family
Asteraceae
Distribution
Asia-Temperate
Plant Parts
Not available

Classification

Taxonomy

Atractylis aristata belongs to the vast kingdom Plantae, representing the diverse life found within the plant world. This specific species is classified under the class Equisetopsida and falls within the order Asterales. As a member of the Asteraceae family, it shares botanical characteristics with many well-known flowering plants. Its unique biological identity is further defined by its placement within the genus Atractylis. Understanding these taxonomic relationships provides essential insight into the evolutionary history of this plant.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Asterales
Family Asteraceae
Genus Atractylis

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Atractylis aristata is a resilient species with a broad geographical presence across the African continent. Its distribution spans the vast landscapes of Northern Africa, including the territories of Morocco, Algeria, and Egypt. Moving eastward, the plant also finds a home within the Northeast Tropical regions. Specifically, it can be located throughout Chad and across the borderlands of Sudan and South Sudan. This wide-reaching range highlights the plant's ability to adapt to diverse environments within these various African nations.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Atractylis aristata is characterized by its distinctive growth form as a herbaceous plant.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Compounds

Atractylis aristata serves as a promising source of bioactive compounds that offer significant potential for pharmaceutical development. Detailed phytochemical profiling using UPLC-ESI-MS/MS analysis has confirmed that the plant's aqueous extract contains valuable flavonoids and phenolic acids. These specific constituents contribute to the plant's impressive ability to combat oxidative stress and neutralize free radicals. Furthermore, the presence of these compounds supports the extract's diverse pharmacological activities, including potent anti-inflammatory and antibacterial effects. Ultimately, the rich phytochemical makeup of Atractylis aristata underscores its therapeutic versatility in treating various health conditions.

Conditions

Atractylis aristata demonstrates significant therapeutic potential through its ability to act as a source for antidiabetic agents by inhibiting α-amylase. The plant also exhibits sedative effects that can be utilized to treat anxiety. Its aqueous extract provides strong anti-inflammatory activity, effectively reducing paw edema in vivo. Furthermore, the plant serves as a broad-spectrum antibacterial agent capable of treating various microbial infections. Finally, its rich phytochemical profile allows it to combat oxidative stress through considerable antioxidant activity.

Preparations

Atractylis aristata is prepared as an aqueous extract to investigate its diverse pharmacological properties, including anti-inflammatory, antioxidant, antibacterial, and sedative activities. This aqueous preparation, referred to as AEAA, contains various bioactive compounds like flavonoids and phenolic acids that contribute to its therapeutic potential. Additionally, Atractylis aristata is prepared as an n-butanol extract to facilitate the isolation and structural elucidation of specific fructose-based carbohydrates. Researchers utilized this n-butanol extract to identify saccharides such as 6-kestose, which demonstrates significant α-amylase inhibitory activity. Through these different preparation methods, the plant's chemical profile is leveraged to explore its potential in treating oxidative stress, microbial infections, and diabetes.

Parts used